Biotechnology group Biogen presented this afternoon at the Leerink Partners' 6th Annual Global Healthcare Conference in New York.
Those who were unable to participate in the live event are encouraged to visit www.biogen.com/investors. A taped version of the webcast is available.
A longtime Biologics manufacturer, Biogen's portfolio includes treatments for spinal muscular atrophy. It is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis.
Biogen presents at Global Healthcare Conference
Alerts Sign-up